Heron Therapeutics, Inc.

Heron Therapeutics, Inc.

Heron Therapeutics, Inc.

Overview
Date Founded

1987

Headquarters

4242 Campus Point Court,Suite 200,San Diego, CA 92121

Type of Company

Public

Employees (Worldwide)

223

Industries

Biotechnology
Pharmaceuticals
Hospitals & Patient Services

Company Description

Heron Therapeutics, Inc. is a biotechnology company, which engages in the development of pharmaceutical products for patients suffering from cancer. Its products portfolio include SUSTOL, Cinvanti, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.

Contact Data
Trying to get in touch with decision makers at Heron Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer & Chairman of the Board

President & Chief Commercial Officer

Vice President, Chief Financial & Accounting Officer

Chief Financial Officer & Vice President of Finance

Executive Vice President & Chief Operating Officer

Chief Scientific Officer & Senior Vice President, Pharmaceutical & Translational Sciences

Chief Medical Officer

Executive Vice President, Drug Development & Director

Benefit Plan Administrator

Senior Vice President of Research & Development

Board of Directors

Chief Executive Officer & Chairman of the Board at Heron Therapeutics, Inc.

Chief Executive Officer at ACADIA Pharmaceuticals, Inc.

Former Vice President, Finance, Chief Financial Officer & Secretary at Horizon Pharmaceutical LLC

Secretary, General Counsel & Executive Vice President at Gossamer Bio, Inc.

Chief Commercial Officer at Ardelyx, Inc.

Executive Vice President, Drug Development & Director at Heron Therapeutics, Inc.

Emergency Physician at University of Washington Medical Center

Paths to Heron Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Heron Therapeutics, Inc.
Owners & Shareholders
Details Hidden

Tang Capital focuses on investments in small-cap US companies in the life sciences sector.

Details Hidden

BBA pursues a fundamentally-driven approach to life sciences investing. The firm typically takes large, concentrated positions in the securities of life sciences companies with the potential for significant value creation over the long-term. They focus on public securities, but may, from time to time, recommend investments in private companies, life sciences and related healthcare intellectual property, royalty streams or other non-public investment opportunities.

Details Hidden

Founded in 2007, ArrowMark Partners is an SEC-registered investment adviser headquartered in Denver, CO and adviser to the Meridian Funds family. The founding partners have worked together since 1995.

Recent Transactions
Details Hidden

Heron Therapeutics, Inc. issued . USD Common Stock

Details Hidden

Heron Therapeutics, Inc. issued . USD Common Stock

Details Hidden

Heron Therapeutics, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Transaction Advisors
Auditor

Advised onHeron Therapeutics, Inc. issued . USD Common Stock

Escrow Agent

Advised onHeron Therapeutics, Inc. issued . USD Common Stock

Underwriter

Advised onHeron Therapeutics, Inc. issued . USD Common Stock

Co-Chairman, Life Sciences Practice Group

Advised onHeron Therapeutics, Inc. issued . USD Common Stock

Managing Director

Advised onHeron Therapeutics, Inc. issued . USD Common Stock

Senior Managing Director

Advised onHeron Therapeutics, Inc. issued . USD Common Stock

Advisors & Consultants

Senior Vice President-Operations at Amylin Pharmaceuticals LLC

Key Stats and Financials As of 2020
Market Capitalization
$1.05B
Total Enterprise Value
$1.74B
Earnings Per Share
$-2.5
Revenue
$88.6M
Net Profit
$-227M
Enterprise Value / Sales
19.6x
TEVNet Income
-7.64x
Debt TEV
0.01x
Total Equity
$236M
Total Debt
$24.6M
EBITDAMargin
-254.2%
EBITDA
$-225M
Three Year Compounded Annual Growth Rate Of Revenue
42.29%
Investors
Details Hidden

Annex Ventures invests in early-stage to mid-stage technology companies in a variety of sectors including technology, software, hardware, security, entertainment and consumer products. They also provide private investments in public entities (PIPE), primarily in small cap, public biotech and medical devices. Initial investments range from $0.1 million to $2 million. They also work with other venture capital firms, angel groups and private investors to meet larger capital requirements.

Competitors
Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891.

Mallinckrodt Plc Pharmaceuticals - Blanchardstown, Ireland

Mallinckrodt Plc engages in the development, manufacture, market, adn distribution of both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes innovative specialty pharmaceutical brands. The Specialty Generics segment relates to niche specialty generic drugs and active pharmaceutical ingredients. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Blanchardstown, Dublin.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Heron Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Heron Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Heron Therapeutics, Inc..